Innate Immune Mechanisms in Non-infectious Lung Inflammation
非感染性肺部炎症的先天免疫机制
基本信息
- 批准号:7771704
- 负责人:
- 金额:$ 38.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAlveolar MacrophagesAnimal ModelApplications GrantsAsthmaAwardBloodCell physiologyCell surfaceCellsChronicChronic Obstructive Airway DiseaseCytoprotectionDataECM receptorEffector CellEpithelial CellsEpitheliumEventExcisionExtracellular MatrixFailureFibrosisFundingGene TargetingGlycosaminoglycansHost DefenseHyaluronanImmuneImmune responseImmunologic ReceptorsInfectionInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseInjuryInvadedLaboratoriesLeadLungLung InflammationLung diseasesMacrophage ActivationMediatingMediator of activation proteinMesenchymalMorbidity - disease rateMusNatural ImmunityOutcomePathway interactionsPatientsPlayPolymersProcessProductionPulmonary FibrosisResolutionRoleSignal TransductionSiteSpecificityStructure of parenchyma of lungT-LymphocyteTLR2 geneTLR4 geneTestingTissuesToll-Like Receptor 2Toll-like receptorsWorkadaptive immunityalveolar homeostasischemokinefibrogenesisinjuredinjury and repairlung injurymacromoleculemacrophagemigrationmolecular massneutrophilnovelpathogenpublic health relevancerepairedresponserestoration
项目摘要
DESCRIPTION (provided by applicant): Alveolar macrophages have a fundamental role in regulating the innate host response in host defense against infection. However, there are also circumstances where chronic inflammation and fibrosis persist in the absence of infection. We have found that the extracellular matrix glycosaminoglycan hyaluronan (HA) is a critical regulator of lung injury, inflammation and fibrosis. We have found that HA fragments mediate lung inflammation by interacting with Toll-like receptors 2 and 4 on macrophages to produce inflammatory chemokines in a manner that depends upon the intracellular adaptor protein MyD88. In addition, we have made the unexpected observation that high molecular mass HA on the cell surface of lung epithelial cells is protective against non-infectious lung injury in a TLR2/4/MyD88 manner that appears to involve the constitutive activation of NF-?B. These data suggest that the TLR2/4-MyD88 pathway is a critical regulator of non-infectious lung inflammation through distinct mechanisms on macrophages and epithelial cells. We have also made the observation that TLR4 is protective against lung fibrosis by a mechanism that may involve a MyD88-independent pathway. Collectively, these data have led us to the hypothesis that extracellular matrix has a fundamental role in regulating lung injury, inflammation and repair by distinct interactions with TLRs on infiltrating macrophages and parenchymal epithelial cells. We will test this hypothesis in the following Specific Aims: 1. Define the role of MyD88 signaling in lung epithelial cells and macrophages in regulating non- infectious lung injury and repair using gene targeted mice that only express MyD88 in either the lung epithelium or in tissue macrophages. 2. Characterize the mechanisms of exaggerated fibrogenesis in the absence of TLR4 signaling following non-infectious lung injury. 3. Define the mechanisms by which hyaluronan-TLR interactions maintain alveolar homeostasis in response to non-infectious lung injury. PUBLIC HEALTH RELEVANCE. Chronic lung inflammation contributes to significant morbidity in lung diseases such as pulmonary fibrosis, asthma and COPD. This grant proposal is to find to treatments for lung inflammation by understanding how injured lung tissue causes chronic lung inflammation.
描述(由申请人提供):肺泡巨噬细胞在调节宿主防御感染的先天性宿主反应中具有重要作用。然而,也存在慢性炎症和纤维化在没有感染的情况下持续存在的情况。我们已经发现,细胞外基质糖胺聚糖透明质酸(HA)是肺损伤,炎症和纤维化的关键调节因子。我们已经发现HA片段通过与巨噬细胞上的Toll样受体2和4相互作用以依赖于细胞内衔接蛋白MyD 88的方式产生炎性趋化因子来介导肺部炎症。此外,我们已经取得了意想不到的观察,高分子量HA的细胞表面的肺上皮细胞是保护非感染性肺损伤的TLR 2/4/MyD 88的方式,似乎涉及组成性激活NF-?B。这些数据表明,TLR 2/4-MyD 88途径是通过对巨噬细胞和上皮细胞的不同机制的非感染性肺部炎症的关键调节剂。我们还观察到TLR 4通过可能涉及MyD 88非依赖性途径的机制对肺纤维化具有保护作用。总的来说,这些数据使我们假设细胞外基质在调节肺损伤,炎症和修复中具有重要作用,通过与浸润巨噬细胞和实质上皮细胞上的TLR的不同相互作用。我们将在以下具体目标中检验这一假设:1。使用仅在肺上皮或组织巨噬细胞中表达MyD 88的基因靶向小鼠,确定肺上皮细胞和巨噬细胞中MyD 88信号传导在调节非感染性肺损伤和修复中的作用。2.描述非感染性肺损伤后在缺乏TLR 4信号传导的情况下过度纤维化的机制。3.明确透明质酸-TLR相互作用在非感染性肺损伤时维持肺泡内环境稳定的机制。公共卫生相关性。慢性肺部炎症导致肺部疾病如肺纤维化、哮喘和COPD的显著发病率。这项拨款提案是通过了解受伤的肺组织如何导致慢性肺部炎症来寻找肺部炎症的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Wesley Noble其他文献
Paul Wesley Noble的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Wesley Noble', 18)}}的其他基金
Molecular Regulation of Progressive Pulmonary Fibrosis
进行性肺纤维化的分子调控
- 批准号:
10579263 - 财政年份:2020
- 资助金额:
$ 38.61万 - 项目类别:
Molecular Regulation of Progressive Pulmonary Fibrosis
进行性肺纤维化的分子调控
- 批准号:
9894657 - 财政年份:2020
- 资助金额:
$ 38.61万 - 项目类别:
Molecular Regulation of Progressive Pulmonary Fibrosis
进行性肺纤维化的分子调控
- 批准号:
10352422 - 财政年份:2020
- 资助金额:
$ 38.61万 - 项目类别:
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
纤维增生性肺病中的间充质细胞功能障碍
- 批准号:
10450041 - 财政年份:2012
- 资助金额:
$ 38.61万 - 项目类别:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
调节炎症性和纤维增生性肺病的宿主因素
- 批准号:
8514063 - 财政年份:2012
- 资助金额:
$ 38.61万 - 项目类别:
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
肺纤维化和慢性同种异体移植物功能障碍 (CLAD) 中的上皮-间质相互作用
- 批准号:
10197999 - 财政年份:2012
- 资助金额:
$ 38.61万 - 项目类别:
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
纤维增生性肺病中的间充质细胞功能障碍
- 批准号:
10198011 - 财政年份:2012
- 资助金额:
$ 38.61万 - 项目类别:
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
肺纤维化和慢性同种异体移植物功能障碍 (CLAD) 中的上皮-间质相互作用
- 批准号:
10450037 - 财政年份:2012
- 资助金额:
$ 38.61万 - 项目类别:
相似海外基金
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
- 批准号:
23K08315 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
- 批准号:
MR/X005046/1 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
- 批准号:
23H03154 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
- 批准号:
10607319 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
- 批准号:
471247 - 财政年份:2022
- 资助金额:
$ 38.61万 - 项目类别:
Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
- 批准号:
485971 - 财政年份:2022
- 资助金额:
$ 38.61万 - 项目类别:
Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
- 批准号:
22K06698 - 财政年份:2022
- 资助金额:
$ 38.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
- 批准号:
462596862 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
- 批准号:
21K16251 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
- 批准号:
NC/V001019/1 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
Research Grant